Concepedia

Martin Gosling

MG

Statistics

Publications

32

Citations

1.6K

H-Index

22

Active since

1995

Affiliations

Novartis (Switzerland)(Current)

Novartis (United Kingdom)

Charing Cross Hospital

Novartis Institutes for BioMedical Research

University of Sussex

Martin Gosling is an author at Novartis (Switzerland) specializing in pharmacology, molecular pharmacology, and medicine.

ORCID

Publications per year

1995–2023

32

Publications

32

Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling

Adrian Britschgi, Anke Bill, Heike Brinkhaus et al. · Proceedings of the National Academy of Sciences · 2013 · 321 citations · Full text

, , +17

Drug block of the hERG potassium channel: Insight from modeling

Phillip J. Stansfeld, Peter Gedeck, Martin Gosling et al. · Proteins Structure Function and Bioinformatics · 2007 · 106 citations · Full text

, , +17

TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis

Henry Danahay, Sarah Lilley, Roy Fox et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 96 citations · Full text

, , +17

Camostat Attenuates Airway Epithelial Sodium Channel Function in Vivo through the Inhibition of a Channel-Activating Protease

K. Coote, Hazel C. Atherton-Watson, Rosemary Sugar et al. · Journal of Pharmacology and Experimental Therapeutics · 2009 · 94 citations · Full text

, , +14

Activation of Human TRPC6 Channels by Receptor Stimulation

Mark Estación, Su Li, William G. Sinkins et al. · Journal of Biological Chemistry · 2004 · 93 citations · Full text

, , +17

1–5 of 32